| Literature DB >> 21338872 |
Abstract
The potential use of drugs to enhance cognition, emotion, and executive function has engendered controversy despite the fact that few such agents exist today. Here, I provide a context for discussions based on medical, regulatory, and ethical concerns that have been raised by the possibility that enhancers will emerge from current efforts to discover drugs for neuropsychiatric disorders.Entities:
Mesh：
Substances：
Year: 2011 PMID： 21338872 DOI： 10.1016/j.neuron.2011.02.012
Source DB: PubMed Journal: Neuron ISSN： 0896-6273 Impact factor: 17.173